Figure 4.
Time to clinically meaningful deterioration in HRQL or death. (A) Time to clinically meaningful deterioration in HRQL or death analyses. (B) Time to clinically meaningful deterioration in HRQL only. aStratified HR for EORTC QLQ-C30 for treatment difference. bStratified log-rank test for EORTC QLQ-C30 for treatment difference. EFS, event-free survival.